LOCB
PACB icon

Lombard Odier & Cie (Bahamas)’s Pacific Biosciences PACB Stock Holding History

Lombard Odier & Cie (Bahamas)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,500
Closed -$61K – 90
2014
Q3 		$61K Sell
12,500
-37,500
-75% -$196K 0.02% 69
2014
Q2 		$309K Sell
50,000
-10,000
-17% -$50K 0.11% 51
2014
Q1 		$321K Buy
+60,000
New +$379K 0.13% 50

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MMC
MDV Management Company Menlo Park, California $296M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lombard Odier & Cie (Bahamas)'s PACB Position: Q4 2014 in Review

Lombard Odier & Cie (Bahamas) sold out of Pacific Biosciences (PACB) in Q4 2014, closing a stake of 12,500 shares — an estimated $61K sold.

Lombard Odier & Cie (Bahamas) first reported a position in PACB in Q1 2014 and held it in 3 quarters. The position peaked at $321K in Q1 2014. 101 funds tracked by Wall St. Rank hold PACB as of Q4 2014.

  • Lombard Odier & Cie (Bahamas) reported no remaining Pacific Biosciences position as of Q4 2014 after selling out during the quarter.
  • Lombard Odier & Cie (Bahamas) sold 12,500 Pacific Biosciences shares in Q4 2014, an estimated $61K.
  • Lombard Odier & Cie (Bahamas) first reported a position in Pacific Biosciences in Q1 2014 and held it in 3 quarters.
  • Lombard Odier & Cie (Bahamas)'s Pacific Biosciences position peaked at $321K in Q1 2014.
  • 101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2014.

Based on Lombard Odier & Cie (Bahamas)'s 13F filing for Q4 2014, filed 13 Feb 2015.